ArticleOncoTargets and therapy2016

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial.

Alexandra von Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.